Controlled trial with pegylated interferon-alpha2b plus ribavirin retreatment in patients with chronic hepatitis C not responding to a previous antiviral treatment with standard interferons combined with ribavirin

被引:0
|
作者
Teuber, G
Kallinowski, B
Niederau, C
Klinker, H
Galle, PR
Zankel, M
Zeuzem, S
机构
[1] Med Klin 2, Frankfurt, Germany
[2] Innere Med 4, Heidelberg, Germany
[3] St Josef Hosp, Oberhausen, Germany
[4] Luitpold Krankenhaus, Wurzburg, Germany
[5] Med Klin 1, Mainz, Germany
[6] Essex Pharma, Munich, Germany
关键词
D O I
10.1016/S0168-8278(03)80873-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
607
引用
收藏
页码:176 / 176
页数:1
相关论文
共 50 条
  • [41] Pegylated Interferon Alpha-2a and Ribavirin in the Treatment of Children with Chronic Hepatitis C
    Pawlowska, Malgorzata
    Halota, Waldemar
    GASTROENTEROLOGY, 2009, 136 (05) : A839 - A839
  • [42] Interferon-α alone versus interferon-α plus ribavirin in patients with chronic hepatitis C not responding to previous interferon-α treatment
    Tripi, S
    Di Gaetano, G
    Soresi, M
    Cartabellotta, F
    Vassallo, R
    Carroccio, A
    Anastasi, G
    Montalto, G
    BIODRUGS, 2000, 13 (04) : 299 - 304
  • [43] Combined Antiviral Therapy for Hepatitis C with Pegylated Interferon Alpha and Ribavirin is Not Less Effective in Elderly Patients
    Frei, Pascal
    Leucht, Anna Katharina
    Held, Ulrike
    Kofmehl, Reto
    Rau, Monika
    Gerlach, Tilman
    Negro, Francesco
    Heim, Markus
    Moradpour, Darius
    Cerny, Andreas
    Dufour, Jean-Francois
    Mullhaupt, Beat
    Geier, Andreas
    SWISS MEDICAL WEEKLY, 2011, 141 : 17S - 17S
  • [44] Pegylated interferon α-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-coinfected patients
    Voigt, Esther
    Schulz, Christian
    Klausen, Gerd
    Goelz, Joerg
    Mauss, Stefan
    Schmutz, Guenther
    Jessen, Heiko
    Weitner, Lutwin
    Mutz, Antonius
    Schranz, Dietmar
    Rockstroh, Juergen K.
    JOURNAL OF INFECTION, 2006, 53 (01) : 36 - 42
  • [45] Efficacy and Tolerability of Pegylated Interferon-α2a plus Ribavirin versus Pegylated Interferon-α2b plus Ribavirin in Treatment-Naive Chronic Hepatitis C Patients
    Lee, Seok
    Kim, In Hee
    Kim, Seong Hun
    Kim, Sang Wook
    Lee, Seung Ok
    Lee, Soo Teik
    Kim, Dae Ghon
    Lee, Chang Seop
    Choi, Chang Soo
    Cho, Eun Young
    Kim, Haak Cheoul
    INTERVIROLOGY, 2010, 53 (03) : 146 - 153
  • [46] Peg interferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for treatment of chronic hepatitis C in treatment-naive patients in Egypt
    Elwaki, M. R.
    Montasser, M. F.
    Mansour, M. A.
    Salman, T. A.
    El-Batanony, M. H.
    Helail, E. H.
    Shehata, K. O.
    Attallah, K. M.
    Madwar, M. A.
    LIVER INTERNATIONAL, 2006, 26 : 84 - 84
  • [47] Pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients
    Moreno, L
    Quereda, C
    Moreno, A
    Perez-Elías, MJ
    Antela, A
    Casado, JL
    Dronda, F
    Mateos, ML
    Bárcena, R
    Moreno, S
    AIDS, 2004, 18 (01) : 67 - 73
  • [48] Predictive factors of response to pegylated interferon α-2a and ribavirin in chronic hepatitis C Egyptian patients with genotype 4 not responding previously to standard interferon and ribavirin
    El Khayat, H.
    Maher, M.
    Ismail, A.
    Gabr, M.
    Salama, H.
    LIVER INTERNATIONAL, 2006, 26 : 17 - 18
  • [49] Treatment of chronic hepatitis C with pegylated interferon alfa-2a plus ribavirin in hemophiliac patients
    Malekzadeh, R
    Merat, S
    Sohrabpour, AA
    Khaleghi, S
    Samimi-Rad, K
    GASTROENTEROLOGY, 2004, 126 (04) : A431 - A431
  • [50] Neutralizing antibodies to interferon alpha in chronic hepatitis C patients non-responding to pegylated interferon plus ribavirin retreated to PEG-interferon α2a and ribavirin (ANRS gammatri)
    Halfon, Philippe
    Perusat, Sophie
    Bourliere, Marc
    Bronowicki, Jean-Pierre
    Trimoulet, P.
    Benhamou, Yves
    Leroy, V.
    Marcellin, Patrick
    Foucher, J.
    Chene, Genevieve
    Couzigou, Patrice
    HEPATOLOGY, 2007, 46 (04) : 669A - 669A